As one of the important scientific cores of the Center for the Molecular Biology of Neurosensory Systems, the goals of Mouse Genome Engineering Core facility (MGECF) are i) to serve all the needs of CoBRE investigators related to the design and creation of transgenic and knockout mouse models, ii) undertake technological research to continuously Improve genetic engineering methods and iii) to provide education and training opportunities to students, researchers and faculty. MGECF was supported by CoBRE during its Phase I at which time the facility was in the initial stages of development. By the end of Phase I the facility was fully functional in creating the mouse models by employing standard mouse embryo manipulation techniques such as microinjection and transferring into pseudo-pregnant females. During the CoBRE phase II period the facility has achieved significant accomplishments: i) started offering critical services such as the design and building of transgenic and targeting vectors that were done previously by the investigators;ii) initiated many other services such as mouse genotyping and speed congenics;iii) acquired additional equipment and personnel and provided training to enhance their overall skills (both scientific and administrative);and iv) initiated research on the most advanced genome engineering methods to validate them for offering as new services. Notably, the MGECF is among the first three such core facilities in the nation that started offering'the genome editing service TALENs (Transcription Activator Like Effector Nucleases). The core almost tripled its user base in 2010 and has maintained it at that level since then. It has has successfully increased its revenue in the recent three years, becoming less dependent of CoBRE support and demonstrating its capability to become sustainable in the future. This core facility is one of the most critical core facilities in the region that serves many investigators across three different institutes. Because of necessity as well as its remarkable success, the MGECF is supported by the UNMC office of the Vice Chancellor for Research. Additionally, the VCR office has a strong commitment to provide support beyond Phase III of CoBRE support.
Research into the genetic causes of neurodeveiopmental disorders is dependent upon the skilled creation of animal models that allow investigation of developmental processes and innovative treatments. The Mouse Genome Engineering Core provides a broad array of high quality services and training for researchers, and also performs its own research to introduce new technologies.
|Ka, Minhan; Chopra, Divyan A; Dravid, Shashank M et al. (2016) Essential Roles for ARID1B in Dendritic Arborization and Spine Morphology of Developing Pyramidal Neurons. J Neurosci 36:2723-42|
|Dufek, Brianna; Meehan, Daniel T; Delimont, Duane et al. (2016) Endothelin A receptor activation on mesangial cellsÂ initiates Alport glomerular disease. Kidney Int 90:300-10|
|Gurumurthy, Channabasavaiah B; Takahashi, Gou; Wada, Kenta et al. (2016) GONAD: A Novel CRISPR/Cas9 Genome Editing Method that Does Not Require Ex Vivo Handling of Embryos. Curr Protoc Hum Genet 88:Unit 15.8|
|Ka, Minhan; Kim, Woo-Yang (2016) Microtubule-Actin Crosslinking Factor 1 Is Required for Dendritic Arborization and Axon Outgrowth in the Developing Brain. Mol Neurobiol 53:6018-6032|
|Yilmazer-Hanke, Deniz; O'Loughlin, Elaine; McDermott, Kieran (2016) Contribution of amygdala pathology to comorbid emotional disturbances in temporal lobe epilepsy. J Neurosci Res 94:486-503|
|Meehan, Daniel T; Delimont, Duane; Dufek, Brianna et al. (2016) Endothelin-1 mediated induction of extracellular matrix genes in strial marginal cells underlies strial pathology in Alport mice. Hear Res 341:100-108|
|Schulze, Thomas T; Ali, Jonathan M; Bartlett, Maggie L et al. (2016) De novo Assembly and Analysis of the Chilean Pencil Catfish Trichomycterus areolatus Transcriptome. J Genomics 4:29-41|
|Wong, Chuu-Yun A; Jiang, Haihong; Abel, Peter W et al. (2016) Phorbol myristate acetate suppresses breast cancer cell growth via down-regulation of P-Rex1 expression. Protein Cell 7:445-9|
|Sato, Masahiro; Ohtsuka, Masato; Watanabe, Satoshi et al. (2016) Nucleic acids delivery methods for genome editing in zygotes and embryos: the old, the new, and the old-new. Biol Direct 11:16|
|Kristensen, Anders S; Hansen, Kasper B; Naur, Peter et al. (2016) Pharmacology and Structural Analysis of Ligand Binding to the Orthosteric Site of Glutamate-Like GluD2 Receptors. Mol Pharmacol 89:253-62|
Showing the most recent 10 out of 45 publications